Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis Press Release
AANEM Virtual Industry Forum Oct 25, 2025 3:30 PM EDT Webcast Supporting Materials Virtual Industry Forum Presentation 4.2 MB
